announces

Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering

February 06, 2026 09:25 ET  | Source: Ernexa Therapeutics Inc. CAMBRIDGE, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics…

1 week ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon…

1 week ago

Cannabix Technologies announces Non-Brokered LIFE Private Placement

February 06, 2026 19:00 ET  | Source: Cannabix Technologies Inc.   NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR…

2 weeks ago

HarperCollins Publishers India Announces the Forthcoming Publication of Smarter Than the Storm, A New Book by Amitabh Kant and Siddharth Sinha

NEW DELHI, Feb. 6, 2026 /PRNewswire/ -- HarperCollins Publishers India is proud to announce the forthcoming publication of Smarter Than the…

2 weeks ago

TAT announces Amazing Thailand Chinese New Year 2026 in Bangkok and Hat Yai marking 51 years of Thailand-China relations

A nationwide programme is expected to stimulate travel demand and generate more than 42 billion Baht in tourism revenueBANGKOK, Feb.…

2 weeks ago

Casio Announces Ambassador Partnership with Pro Skateboarder Yuto Horigome

Sharing the World of G-SHOCK with a Global AudienceTOKYO, Feb. 5, 2026 /PRNewswire/ -- Casio Computer Co., Ltd. announced today…

2 weeks ago

Axtria Announces Ignite Global 2026: “Beyond Capabilities. Into Ownership. Fuelled by AI.”

NEW DELHI, Feb. 3, 2026 /PRNewswire/ -- Axtria Inc., a global leader in AI-first data analytics solutions for the life…

2 weeks ago

Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Initiation of trial marks first-in-human milestone for Neomorph’s novel molecular glue degrader platform February 03, 2026 13:08 ET  | Source:…

2 weeks ago

RESTEM Announces First Patient Dosed in the Phase 2/3 IIMPACT Study of Restem-L in Idiopathic Inflammatory Myopathy

February 03, 2026 13:06 ET  | Source: Restem Initiation of the IIMPACT study follows promising Phase 1 results where Restem-L…

2 weeks ago

Cango Inc. Announces January 2026 Bitcoin Production and Mining Operations Update

DALLAS, Feb. 3, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading Bitcoin miner leveraging its…

2 weeks ago